JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 9, 2005; DOI: 10.1124/jpet.105.087965


0022-3565/05/3143-1310-1321$20.00
JPET 314:1310-1321, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.087965v1
314/3/1310    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lim, H. D.
Right arrow Articles by Leurs, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lim, H. D.
Right arrow Articles by Leurs, R.

CELLULAR AND MOLECULAR

Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor Agonist

Herman D. Lim1, Richard M. van Rijn1, Ping Ling, Remko A. Bakker, Robin L. Thurmond, and Rob Leurs

Leiden/Amsterdam Center for Drug Research, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (H.D.L., R.M.v.R., R.A.B., R.L.); and Johnson & Johnson Pharmaceutical Research & Development, L.L.C., San Diego, California (P.L., R.L.T.)

The histamine H4 receptor (H4R) is involved in the chemotaxis of leukocytes and mast cells to sites of inflammation and is suggested to be a potential drug target for asthma and allergy. So far, selective H4R agonists have not been identified. In the present study, we therefore evaluated the human H4R (hH4R) for its interaction with various known histaminergic ligands. Almost all of the tested H1R and H2R antagonists, including several important therapeutics, displaced less than 30% of specific [3H]histamine binding to the hH4R at concentrations up to 10 µM. Most of the tested H2R agonists and imidazole-based H3R ligands show micromolar-to-nanomolar range hH4R affinity, and these ligands exert different intrinsic hH4R activities, ranging from full agonists to inverse agonists. Interestingly, we identified 4-methylhistamine as a high-affinity H4R ligand (Ki = 50 nM) that has a >100-fold selectivity for the hH4R over the other histamine receptor subtypes. Moreover, 4-methylhistamine potently activated the hH4R (pEC50 = 7.4 ± 0.1; {alpha} = 1), and this response was competitively antagonized by the selective H4R antagonist JNJ 7777120 [1-[(5-chloro-1H-indol-2-yl)-carbonyl]-4-methylpiperazine] (pA2 = 7.8). The identification of 4-methylhistamine as a potent H4R agonist is of major importance for future studies to unravel the physiological roles of the H4R.


Received April 13, 2005; accepted June 1, 2005.

Address correspondence to: Dr. R. Leurs, Leiden/Amsterdam Center for Drug Research, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands. E-mail: r.leurs{at}few.vu.nl




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Francis, S. Glaser, S. DeMorrow, E. Gaudio, Y. Ueno, J. Venter, D. Dostal, P. Onori, A. Franchitto, M. Marzioni, et al.
Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C499 - C513.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. L. Haas, O. A. Sergeeva, and O. Selbach
Histamine in the Nervous System
Physiol Rev, July 1, 2008; 88(3): 1183 - 1241.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Pos, Z. Wiener, P. Pocza, M. Racz, S. Toth, Z. Darvas, V. Molnar, H. Hegyesi, and A. Falus
Histamine Suppresses Fibulin-5 and Insulin-like Growth Factor-II Receptor Expression in Melanoma
Cancer Res., March 15, 2008; 68(6): 1997 - 2005.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
J. Kool, A. Van Marle, S. Hulscher, M. Selman, D. J. Van Iperen, K. Van Altena, M. Gillard, R. A. Bakker, H. Irth, R. Leurs, et al.
A Flow-Through Fluorescence Polarization Detection System for Measuring GPCR-Mediated Modulation of cAMP Production
J Biomol Screen, December 1, 2007; 12(8): 1074 - 1083.
[Abstract] [PDF]


Home page
J. Physiol.Home page
E. Breunig, K. Michel, F. Zeller, S. Seidl, C. W. H. v. Weyhern, and M. Schemann
Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors
J. Physiol., September 1, 2007; 583(2): 731 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. K. Morgan, B. McAllister, L. Cross, D. S. Green, H. Kornfeld, D. M. Center, and W. W. Cruikshank
Histamine 4 Receptor Activation Induces Recruitment of FoxP3+ T Cells and Inhibits Allergic Asthma in a Murine Model
J. Immunol., June 15, 2007; 178(12): 8081 - 8089.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. M. van Rijn, P. L. Chazot, F. C. Shenton, K. Sansuk, R. A. Bakker, and R. Leurs
Oligomerization of Recombinant and Endogenously Expressed Human Histamine H4 Receptors
Mol. Pharmacol., August 1, 2006; 70(2): 604 - 615.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.